No Data
No Data
Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
Virtual Investor Releases Next Wave of "Top 5 for '25" On-Demand Videos
Moleculin to Present at the 37th Annual ROTH Conference
Express News | Moleculin Biotech Inc: New Patents Will Extend Coverage to Major Markets Outside U.S.
Moleculin Biotech Received Notice Of Intent To Grant For Eurpean Patent Application Titled "Method of Reconstituting Liposomal Annamycin".
Express News | Moleculin Biotech Received Notice Of Intent To Grant For Eurpean Patent Application Titled "Method of Reconstituting Liposomal Annamycin"